Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

ISAL 2025

The 19th International Symposium on Acute Leukemias

16–19 March 2025 | Munich, Germany

The 19^th International Symposium on Acute Leukemias (ISALXIX) took place on March 16-19, 2025 in Munich, Germany, and covered the most exciting updates in the biology and treatment of acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and acute promyelocytic leukemia (APL).

View all videos

Venetoclax resistance in AML

Curtis Lachowiez et al. • 17 Mar 2025

Menin inhibition in AML: clinical guidance and future directions

Charles Craddock et al. • 18 Mar 2025

Studying AML in mouse models: methods and challenges

Christina Mayerhofer • 21 Mar 2025

Potential treatment options for patients with AML with low expression of ZBTB7A

Vanessa C. Arfelli • 19 Mar 2025

Venetoclax resistance in AML

Curtis Lachowiez et al. • 17 Mar 2025

Menin inhibition in AML: clinical guidance and future directions

Charles Craddock et al. • 18 Mar 2025

Studying AML in mouse models: methods and challenges

Christina Mayerhofer • 21 Mar 2025

Potential treatment options for patients with AML with low expression of ZBTB7A

Vanessa C. Arfelli • 19 Mar 2025

Targeting mitochondrial metabolism in hematopoietic stem cells for the treatment of acute leukemias

Els Mansell • 21 Mar 2025

Using CRISPR/Cas9 to identify potential therapeutic targets in acute leukemia PDX cells

Binje Vick • 18 Mar 2025

Novel approaches in APL: combining oral arsenic with ATRA

Maria Teresa Voso • 17 Mar 2025

The biggest challenges in managing APL: differentiation syndrome and early deaths

Maria Teresa Voso • 17 Mar 2025